Presentation by our Keynote Speaker, Leslie J. Kohman, MD at our Cancer Mission 2020 28th Congressional District Summit in Buffalo, NY. Dr. Kohman is the Professor of Surgery Medical Director at Upstate Cancer Center in Syracuse, NY.
One example of how Clinical Cancer Registry level data can review practice va...Cancer Institute NSW
We examined the possible utility of using Cancer Institute NSW Clinical Cancer Registry data by examining one contentious issue in radiation oncology as an example. Increasing evidence has been published about the safety and efficacy of hypofractionated radiotherapy, in comparison with standard fractionation, in early, node-negative breast cancer.
Presentation by our Keynote Speaker, Leslie J. Kohman, MD at our Cancer Mission 2020 28th Congressional District Summit in Buffalo, NY. Dr. Kohman is the Professor of Surgery Medical Director at Upstate Cancer Center in Syracuse, NY.
One example of how Clinical Cancer Registry level data can review practice va...Cancer Institute NSW
We examined the possible utility of using Cancer Institute NSW Clinical Cancer Registry data by examining one contentious issue in radiation oncology as an example. Increasing evidence has been published about the safety and efficacy of hypofractionated radiotherapy, in comparison with standard fractionation, in early, node-negative breast cancer.
Dr. Jeff Gershenwald presents a recap of the Surgeon General's Call to Action at the MRF's Patient Symposium at MD Anderson Cancer Center on January 31, 2015.
Introducing VESPIR: a new open-source software to investigate CT ventilation ...Cancer Institute NSW
Computed tomography ventilation imaging (CTVI) is an exciting new functional lung imaging modality enabling functionally adaptive lung cancer radiotherapy treatments. In 2015, this became clinical reality with the first patient treatment performed in the US. Unfortunately the development of new CTVI workflows in the clinic can be challenging, due to the requisite advanced four-dimensional (4D) image processing. To overcome this, we have developed VESPIR (VEntilation via Scripted Pulmonary Image Registration), a user-friendly software toolkit to help streamline the end-to-end validation of CTVI workflows in the clinic.
Next Generation Dx Summit 2015 - Moving Assays to the ClinicJames Prudhomme
The Next Generation Dx Summit, entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this year’s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014Hivlife Info
In this downloadable slide set, Marcy S. Gelman, RN, MSN, MPH, and Kevin M. O’Hara, PA, review essential considerations for midlevel providers administering PrEP
Format: Microsoft PowerPoint (.ppt)
File size: 825 KB
Date posted: 9/29/2014
The Canadian Cancer Survivor Network (CCSN) conducted a survey in April 2013 the discover the impact that being involved in volunteer advocacy and/or the development of public policy has on cancer patients, survivors, caregivers and family members. 51 people completed the survey. Findings were that patient advocacy generally has a positive impact on the self-image of those doing it, that many volunteer advocates felt better, prouder, more useful, more hopeful, more effective and more powerful. Still others felt less angry, less anxious, and less sad. But some survey respondents did feel sadder, angrier, less hopeful and less content. CCSN recommends that organizations ensure that cancer patients involved in advocacy activities receive skills to help them and support to deal with the often slow-moving and sometimes frustrating healthcare, cancer care and government systems in Canada.
HIV Alert :Updating Your Practice Based on New Guideline Recommendations.2016hivlifeinfo
In this downloadable slideset, Eric S. Daar, MD, and Paul E. Sax, MD, review recent updates to expert guideline recommendations for ART—including new initial therapy recommendations, revised guidance on switch strategies for virologically suppressed patients, and other key recommendation updates.
Format: Microsoft PowerPoint (.ppt)
File size: 1.09 MB
Date posted: 9/19/2016
Professor Martin Wiseman presentation on The Continuous Update Project: Novel approach to reviewing mechanistic evidence on diet, nutrition, physical activity and cancer at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...Cancer Institute NSW
The commonly understood model of shift to shift nursing handover does not apply to most ambulatory day treatment units. Nonetheless, ‘handover’ of patient clinical information remains quintessential to safe clinical practice. Of considerable interest is how EMR may aid the transfer of patient clinical information in these circumstances and address the question: does this facilitate improved patient care?
In this downloadable slideset, Joel E. Gallant, MD, MPH, reviews the evidence behind the latest antiretroviral guidelines and offers a glimpse at upcoming agents currently under investigation.
Format: Microsoft PowerPoint (.ppt)
File size: 3.00 MB
Date posted: 6/15/2015
Anti-cancer therapy is big business. In Australia alone between 2000 and 2009, cancer-related pharmaceutical expenditure has risen over 200% to over half a billion dollars per annum.
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусной супрессией и ...hivlifeinfo
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусной супрессией и у пациентов с вирусологической неудачей. /Contemporary Management of HIV. Modifying Antiretroviral Therapy in Virologically Suppressed Patients and Those With Treatment Failure.2016
In this downloadable slideset, W. David Hardy, MD, and Program Director Eric S. Daar, MD review key data and optimal approaches for modifying ART in patients who are virologically suppressed or have experienced treatment failure.
Format: Microsoft PowerPoint (.ppt)
File size: 2.07 MB
Tonight’s speakers: Dr. Dan Sargent and Kim Ryan
Disclaimer: “This Report is not an official event of the 2012 Gastrointestinal Cancers Symposium. Not sponsored or endorsed by any of the cosponsoring organizations of the 2012 Gastrointestinal Cancers Symposium.”
Dr. Jeff Gershenwald presents a recap of the Surgeon General's Call to Action at the MRF's Patient Symposium at MD Anderson Cancer Center on January 31, 2015.
Introducing VESPIR: a new open-source software to investigate CT ventilation ...Cancer Institute NSW
Computed tomography ventilation imaging (CTVI) is an exciting new functional lung imaging modality enabling functionally adaptive lung cancer radiotherapy treatments. In 2015, this became clinical reality with the first patient treatment performed in the US. Unfortunately the development of new CTVI workflows in the clinic can be challenging, due to the requisite advanced four-dimensional (4D) image processing. To overcome this, we have developed VESPIR (VEntilation via Scripted Pulmonary Image Registration), a user-friendly software toolkit to help streamline the end-to-end validation of CTVI workflows in the clinic.
Next Generation Dx Summit 2015 - Moving Assays to the ClinicJames Prudhomme
The Next Generation Dx Summit, entering its seventh year, brings together more than 800 diagnostics professionals from across the world, providing comprehensive programming and valuable networking opportunities. Spanning from clinical diagnostics to business strategy, this year’s expanded program encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer immunotherapy, and reimbursement. With widespread coverage of all the most relevant diagnostics topics, the Next Generation Dx Summit promises to be a must-attend event to hear the latest announcements and developments in this rapidly evolving field.
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014Hivlife Info
In this downloadable slide set, Marcy S. Gelman, RN, MSN, MPH, and Kevin M. O’Hara, PA, review essential considerations for midlevel providers administering PrEP
Format: Microsoft PowerPoint (.ppt)
File size: 825 KB
Date posted: 9/29/2014
The Canadian Cancer Survivor Network (CCSN) conducted a survey in April 2013 the discover the impact that being involved in volunteer advocacy and/or the development of public policy has on cancer patients, survivors, caregivers and family members. 51 people completed the survey. Findings were that patient advocacy generally has a positive impact on the self-image of those doing it, that many volunteer advocates felt better, prouder, more useful, more hopeful, more effective and more powerful. Still others felt less angry, less anxious, and less sad. But some survey respondents did feel sadder, angrier, less hopeful and less content. CCSN recommends that organizations ensure that cancer patients involved in advocacy activities receive skills to help them and support to deal with the often slow-moving and sometimes frustrating healthcare, cancer care and government systems in Canada.
HIV Alert :Updating Your Practice Based on New Guideline Recommendations.2016hivlifeinfo
In this downloadable slideset, Eric S. Daar, MD, and Paul E. Sax, MD, review recent updates to expert guideline recommendations for ART—including new initial therapy recommendations, revised guidance on switch strategies for virologically suppressed patients, and other key recommendation updates.
Format: Microsoft PowerPoint (.ppt)
File size: 1.09 MB
Date posted: 9/19/2016
Professor Martin Wiseman presentation on The Continuous Update Project: Novel approach to reviewing mechanistic evidence on diet, nutrition, physical activity and cancer at FENS European Nutrition Conference, 20-23 October 2015 Berlin (Germany).
Optimising the Model of Care for Patient Management at The Tweed Cancer Care ...Cancer Institute NSW
The commonly understood model of shift to shift nursing handover does not apply to most ambulatory day treatment units. Nonetheless, ‘handover’ of patient clinical information remains quintessential to safe clinical practice. Of considerable interest is how EMR may aid the transfer of patient clinical information in these circumstances and address the question: does this facilitate improved patient care?
In this downloadable slideset, Joel E. Gallant, MD, MPH, reviews the evidence behind the latest antiretroviral guidelines and offers a glimpse at upcoming agents currently under investigation.
Format: Microsoft PowerPoint (.ppt)
File size: 3.00 MB
Date posted: 6/15/2015
Anti-cancer therapy is big business. In Australia alone between 2000 and 2009, cancer-related pharmaceutical expenditure has risen over 200% to over half a billion dollars per annum.
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусной супрессией и ...hivlifeinfo
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусной супрессией и у пациентов с вирусологической неудачей. /Contemporary Management of HIV. Modifying Antiretroviral Therapy in Virologically Suppressed Patients and Those With Treatment Failure.2016
In this downloadable slideset, W. David Hardy, MD, and Program Director Eric S. Daar, MD review key data and optimal approaches for modifying ART in patients who are virologically suppressed or have experienced treatment failure.
Format: Microsoft PowerPoint (.ppt)
File size: 2.07 MB
Tonight’s speakers: Dr. Dan Sargent and Kim Ryan
Disclaimer: “This Report is not an official event of the 2012 Gastrointestinal Cancers Symposium. Not sponsored or endorsed by any of the cosponsoring organizations of the 2012 Gastrointestinal Cancers Symposium.”
Dr. Leonard Saltz, MD; Chief, Gastrointestinal Oncology Service; Head, Memorial Sloan Kettering
Dr. Saltz will discuss selected successes and failures in cancer research efforts, and what we can learn from each, and will take a frank look at costs of care, and at business and government policies that are undermining progress and creating disparities in access to affordable, effective care.
Deel II van een presentatie over wat bereikt is én wat nog bereikt moet worden om de wereldbevolking te kunnen blijven voeden, op een duurzame wijze zowel uit sociaal, ecologisch als economisch perspectief.
Over bewezen en onbewezen gezondheidsclaims, en over de echte risico’s van onze voeding.
Deze avond vertelt prof. Verhagen over zin en onzin in onze voeding. “Gelukkig is nu in de wet geregeld dat gezondheidsclaims op voedingsmiddelen wetenschappelijk bewezen moeten zijn. Veel onzinclaims zullen hierdoor op termijn verdwijnen. De schappen zullen er straks weliswaar anders uitzien, maar niet leger worden.”
En hij vertelt dat onze voeding nog nooit zo veilig is geweest. “De echte gezondheidsrisico’s van onze voeding zit niet in allerlei chemische stofjes, maar in te veel eten en vooral in verkeerd eten. Meer nog: een snufje risico hoort er bij. Een beetje risico kan wellicht nodig zijn net als op andere terreinen.“
Making the Most of Your Congressional Meeting
Facilitators: Josh Wimberly and Patti Hollenback
Expert: Emily White, Fight Colorectal Cancer Program Coordinator
Goal: We will review meeting basics and practice what you need to say to your legislators and staff during your Hill meetings to develop a meaningful relationship with legislators.
This presentation partners with the video and is for participants attending ConC 2012 - it is presented by Camille Bonta for the workshops she will lead at the Fight Colorectal Cancer conference. This is the 3rd part in preparing ConC 2012 participants to talk with Members of Congress about Funding for Colorectal Rectal Cancer Research
This prep document partners with the video and is for participants attending ConC 2012 - it is presented by Camille Bonta for the workshops she will lead at the Fight Colorectal Cancer conference.
The Southwest California Legislative Council assigned each of the 17 ballot propositions to one of our Directors / subject matter experts. Each prepared a report noting the title of the proposition, official verbiage, entities in support or opposition to the measure, where the funding came from and what a YES or NO vote means on the ballot. The Council discussed these details and adopted a position based on our Strategic Initiatives and the impact of the proposition on our business community.
Syringe access in the US: an overview of policy and programs following the lifting of the federal funding ban. Presented at the US Conference on AIDS, 9/13/10
SWCLC Directors researched each ballot measure that will appear on the November 2016 California ballot. Based on that research, the Council determined positions to adopt on each proposition based on the measure's impact on our business community in keeping with our Strategic Initiatives.
We encourage you to do your own research with data available at
https://ballotpedia.org/California_2016_ballot_propositions and
http://www.sos.ca.gov/elections/ballot-measures/qualified-ballot-measures/
Please share this slideshow with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
In this webinar:
● A review of the responses from each of the federal political parties received by CCSN to its federal election questionnaire.
● Insights on each party’s health care platform with an emphasis on how those positions might affect cancer care.
● Commentary from two veteran cancer patient advocates: Colleen Savage of the Cancer Advocacy Coalition of Canada and Kathy Barnard of the Save Your Skin Foundation, who will discuss their interpretations of the party positions and what they might mean for patients and the cancer care after the election.
Contact the presenters:
● gjeffcott@3sixtypublicaffairs.com
● colleensavage@rogers.com
● kathysaveyourskin@icloud.com
View the video: https://youtu.be/1BVyYfpnZEQ
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
The Connecticut Health Foundation (CT Health) is pleased to announce the availability of funding to diversify and strengthen oral health advocacy in CT. CT Health anticipates making two awards of up to $40,000 for a two-year period will be made.
For over ten years, CT Health been committed to improving access and quality of oral health care in the state. There is evidence that these efforts have made a measurable difference in access and utilization of oral health care for low-income Connecticut residents, especially children.
The existing community of oral health advocates have been essential to these efforts. To build greater momentum, however, we must increase the number and type of effective advocates who have credibility and influence.
The second part of our theory is supporting the integration of oral health into overall health must be supported to elevate its status.
Similar to Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda (20)
Dr. Murphy presents slides discussing general screening trends in the US, including how the US compares to other countries, different screening modalities, and differences in screening by:
-Age
-Gender
-Geography
-Race/Ethnicity
Looking to kick start your physical activity? Hoping to learn about how body movement can be a huge benefit for CRC patients and survivors? Curious about Climb for a Cure? Join this interactive webinar featuring Karia Coleman, MSK, personal trainer and athletic strength coach, and Fight CRC advocates as they discuss the importance, challenges, and joys of physical activity.
From bowel frequency, pain, and more, many colorectal cancer treatments lead to digestive side effects. Join this webinar with Dr. Cathy Eng to learn all about the digestive system, the side effects that are common due to CRC treatment, and how to manage those side effects.
Maine recently passed major colorectal cancer (CRC) policy at the state level. Join us to listen to their story and learn what worked well for CRC state advocacy!
Indiana just passed major colorectal cancer (CRC) policy this year. Join us to listen to their story and learn what worked well for CRC advocacy in Indiana!
Kentucky was one of the first states in the US to pass major colorectal cancer (CRC) policy. Join us to listen to their story and learn what worked well for CRC state advocacy!
Join Fight CRC in a webinar about biomarkers. In this session, Dr. Chris Lieu will focus the discussion on the NTRK biomarker, in addition to ctDNA, and Next-Generation Sequencing.
Join us as Eden Stotsky-Himelfarb, BSN, RN from Johns Hopkins Medicine discusses how to manage after a colorectal cancer diagnosis. In this session, she will cover understanding diagnoses, shared decision making, managing mental health, talking to family and colleagues, and more.
Some colorectal cancer treatments lead to side effects of the skin. In this webinar, Dr. Nicole LeBoeuf will discuss these specific side effects. She will talk about why they occur, how to prepare for them, and how to manage them.
Hear about the latest breaking colorectal cancer research! Fight CRC will be joined by Dr. Axel Grothey who will spend the hour detailing the research presented at the 2020 Gastrointestinal (GI) Cancers Symposium hosted by the American Society of Clinical Oncology.
Anticipating the end of life and making decisions about medical care at this time can be difficult and distressing for people with cancer and their loved ones. However, it is incredibly important to plan for the transition to end-of-life care.
In this webinar, we will discuss questions to ask when considering an end to curative treatment, what to expect with hospice and end-of-life care, a new medical care team, advance directives and healthcare proxies, options for pain, the role of caregivers and loved ones, and more.
In this webinar, Dr. Angela Nicholas, Dr. Chris Heery, and Wenora Johnson discuss all things clinical trials. Dr. Nicholas, a family practitioner and caregiver to her late husband, John MacCleod will dive into her experience searching for clinical trials along with advice to those currently searching, or planning on searching in the future. Dr. Heery, Chief Medical Officer for Precision Biosciences will spend time dispelling myths around clinical trials and challenges to enrollment, and Wenora Johnson, a stage III colon cancer survivor will describe the process and her point of view curating trials in the Fight CRC trial finder.
In this webinar, Dr. Popp will discuss everything you need to know about palliative care! This is an important webinar for colorectal cancer patients and their loved ones.
eeling worn out and exhausted all the time? You may be experiencing cancer-related fatigue. Tune in to this webinar to learn what cancer-related fatigue is, how to spot it, and how to manage it.
In this webinar, Dr. Azad discusses colorectal cancer recurrence. She addresses things to do to help reduce the risk of recurrence, in addition to what steps should be taken if colon or rectal cancer returns.
Join Fight CRC and Dr. Scott Kopetz to learn about the latest breaking colorectal cancer research from the American Society of Clinical Oncology 2019 Annual Conference.
May 2019 – What You Need to Know About Chemotherapy Induced Neuropathy WebinarFight Colorectal Cancer
Neuropathy is a common side effect for colorectal cancer patients. It is a side effect that can be incredibly challenging to manage, and can affect daily living. Join this informative webinar to learn all about neuropathy—why it happens, how to prepare for it, and methods to try and reduce its effects. This is an important webinar for all survivors and patients! Dana will speak from both the medical professional and patient angle, as she is a colon cancer survivor herself!
A cancer diagnosis and cancer treatment can be traumatic. An experience with cancer can lead to serious psychological distress that should be addressed. In this webinar, Schuyler Cunningham, Clinical Social Worker, talks about what trauma is, how to identify it, and what steps to take next.
role of women and girls in various terror groupssadiakorobi2
Women have three distinct types of involvement: direct involvement in terrorist acts; enabling of others to commit such acts; and facilitating the disengagement of others from violent or extremist groups.
03062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
‘वोटर्स विल मस्ट प्रीवेल’ (मतदाताओं को जीतना होगा) अभियान द्वारा जारी हेल्पलाइन नंबर, 4 जून को सुबह 7 बजे से दोपहर 12 बजे तक मतगणना प्रक्रिया में कहीं भी किसी भी तरह के उल्लंघन की रिपोर्ट करने के लिए खुला रहेगा।
31052024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
01062024_First India Newspaper Jaipur.pdfFIRST INDIA
Find Latest India News and Breaking News these days from India on Politics, Business, Entertainment, Technology, Sports, Lifestyle and Coronavirus News in India and the world over that you can't miss. For real time update Visit our social media handle. Read First India NewsPaper in your morning replace. Visit First India.
CLICK:- https://firstindia.co.in/
#First_India_NewsPaper
हम आग्रह करते हैं कि जो भी सत्ता में आए, वह संविधान का पालन करे, उसकी रक्षा करे और उसे बनाए रखे।" प्रस्ताव में कुल तीन प्रमुख हस्तक्षेप और उनके तंत्र भी प्रस्तुत किए गए। पहला हस्तक्षेप स्वतंत्र मीडिया को प्रोत्साहित करके, वास्तविकता पर आधारित काउंटर नैरेटिव का निर्माण करके और सत्तारूढ़ सरकार द्वारा नियोजित मनोवैज्ञानिक हेरफेर की रणनीति का मुकाबला करके लोगों द्वारा निर्धारित कथा को बनाए रखना और उस पर कार्यकरना था।
In a May 9, 2024 paper, Juri Opitz from the University of Zurich, along with Shira Wein and Nathan Schneider form Georgetown University, discussed the importance of linguistic expertise in natural language processing (NLP) in an era dominated by large language models (LLMs).
The authors explained that while machine translation (MT) previously relied heavily on linguists, the landscape has shifted. “Linguistics is no longer front and center in the way we build NLP systems,” they said. With the emergence of LLMs, which can generate fluent text without the need for specialized modules to handle grammar or semantic coherence, the need for linguistic expertise in NLP is being questioned.
Fight Colorectal Cancer Legislative & Regulatory 2013 Agenda
1. FIGHT COLORECTAL CANCER
LEGISLATIVE AND
REGULATORY AGENDA
2013
http://fightcolorectalcancer.org/policy
2. Funding for the Centers for Disease
Control and Prevention’s (CDC) Colorectal
Cancer Control Program (CRCCP)
• The CRCCP currently provides funding
through 2014 to 25 states and four
tribal organizations for implementation
of colorectal cancer
education, awareness and screening
programs.
• The CRCCP was funded at $43 million
in FY 2011 and FY 2012.
3. • Over the past few years, Fight Colorectal
Cancer has advocated for increasing the
CRCCP’s budget to $70 million. It is
estimated, that $70 million would allow the CDC
to expand the CRCCP nationally.
• Fight Colorectal Cancer has also fought against
consolidating the CRCCP with the other CDC
cancer control programs or other chronic
disease programs.
The President’s FY 2012 and 2013 budgets
called for consolidation, but the proposal has not
received much support to date from Congress.
4. • Last year, the Senate Appropriations
Committee approved its Labor-HHS-
Education spending bill, which flat
funds the CRCCP in FY 2013.
However, final action on a FY 2013
Labor-HHS-Education spending bill is
still pending.
• http://www.appropriations.senate.gov/
5. • Recommendation: Fight Colorectal
Cancer will advocate for increased
funding for the CRCCP to $70 million
in FY 2014 and continue to oppose
consolidation of the cancer control
programs.
6. Funding for the Department of
Defense (DoD) Peer Reviewed
Cancer Research Program (PRCRP)
• The PRCRP falls under the Congressionally
Directed Medical Research Programs
(CDMRPs), which funds research for
colorectal cancer, among other cancers.
A hallmark of the CDMRPs is their focus on
innovative, multidisciplinary research. PRCRP
funding specifically supports research on
designated cancers with relevance to military
service members and their families.
7. • Fight Colorectal Cancer requested $16
million for the PRCRP in FY 2013.
The program is currently funded at $12.8
million. Increasing PRCRP funding by $3.2
million would restore program funding to
FY 2011 levels.
• Last year, the House approved its FY 2013
DoD spending bill, which includes $15
million for the PRCRP.
However, final action on a FY 2013 DoD
spending bill is still pending.
8. Fight Colorectal Cancer will advocate to
increase funding for the PRCRP to $16
million in FY 2014.
9. Funding for the National Cancer
Institute (NCI)
• The NCI funds critical colorectal cancer research, including
through the Specialized Programs of Research
Excellence, which enables rapid and efficient movement of
basic scientific findings into clinical settings.
• Last year, Fight Colorectal Cancer requested that the
National Institutes of Health (NIH) be funded at $32.7 billion
in FY 2013, which would provide the NCI with $5.36 billion.
In June, the Senate Appropriations Committee approved its
Labor-HHS-Education spending bill, which would boost
funding to the NIH by $100 million, for a total of $30.7 billion.
Of that amount, $5.084 billion is allocated to the NCI, which
constitutes a $15 million increase.
The House Labor-HHS-Education would flat fund the NIH at
$30.6 million. The result is a $2 million cut to the NCI. Final
action on a FY 2013 Labor-HHS-Education spending bill is
still pending
10. • Recommendation: Fight Colorectal
Cancer will advocate for increased
funding for the NIH to $32.623 billion
and NCI to $5.349 billion in FY 2014
11. Federal Funding Sequestration
• In August 2011, Senate Democrats and House Republicans brokered a
compromise to trim $2 trillion from the budget deficit. Under the deal, $1 trillion
in spending cuts will occur across defense and non-defense spending programs
and will be phased in over 10 years. An additional $1.2 trillion in cuts will occur
over the next 10 years through a process of automatic across-the-board
spending cuts, or sequestration, of both defense and non-defense programs.
• Sequestration is required because the congressional Joint Select Committee on
Deficit Reduction, which was established by the law, failed to reach agreement
on a deficit reduction plan. Sequestration will take effect on Jan. 2, 2012.
• The Passage of the American Taxpayer Relief Act in January 2013 delayed
sequestration until March 1, 2013, and the overall amount of cuts was reduced
by $24 billion, equally divided between defense and non-defense programs.
• The Center on Budget and Policy Priorities estimates that if sequestration takes
effect on March 1, NDD programs would be cut more than $26 billion, which
results in an across-the-board cut of 5.1 percent. As a result fewer NIH grants
would be funded and CDC programs would be cut.
12. • Fight Colorectal Cancer will advocate
against sequestration for non-defense
discretionary programs, medical
research and prevention programs in
particular, as well as for a balanced
approach to deficit reduction.
13. Eliminating Cost Sharing for
Colorectal Cancer Screening
Colonoscopy
• Under current law, Medicare beneficiaries must pay a coinsurance when
their colorectal cancer screening colonoscopy also involves the removal
of polyps or other tissue. This policy is confusing to Medicare
beneficiaries and serves as a financial deterrent to this highly effective
method of colorectal cancer prevention.
Additionally, while current law also requires most private payers to cover
colorectal cancer screenings without cost sharing
(copays/coinsurance/deductible), current regulations have resulted in
private payers applying the cost sharing requirements differently. Some
private payers waive cost sharing when a screening involves the removal
of polyps or other tissue, others do not.
• Last year, Fight Colorectal Cancer was instrumental in the introduction of
legislation in the House (H.R. 4120) that would correct Medicare law, and
has lobbied the Department of HHS for a change in regulation.
14. • Fight Colorectal Cancer will seek
reintroduction of corrective legislation
and advocate for its passage in the
113th Congress and continue to lobby
for a change in private payer
regulations.
15. Fight Colorectal Cancer Stamp
Act
• Because funding for medical research through the NIH
has remained essentially flat, in 2010 Fight Colorectal
Cancer championed the introduction of the Colorectal
Cancer Stamp Act (H.R. 893).
This legislation would authorize the U.S. Postal Service
to sell a semipostal, or fundraising, stamp. A colorectal
cancer semipostal stamp will provide needed
supplemental funding for federal colorectal cancer
research and prevention programs without increasing
federal government spending.
Revenues raised from stamp sales would be
distributed to the DoD, CDC, and NIH.
16. • Support reintroduction and advocate
for passage of the Colorectal Cancer
Stamp Act in the House, with the
priority of also identifying a senator(s)
willing to introduce companion
legislation in the Senate
17. Chemotherapy Parity
• Many cancer patients have to pay significantly
more out of pocket for oral anti-cancer
treatments (e.g., pills) than they do for
intravenous treatments.
Legislation was introduced in the 112th Congress
that requires insurers that cover anticancer
medications that are intravenously administered
or injected to provide no less favorable coverage
for oral anticancer medications.
The Cancer Drug Coverage Parity Act was only
introduced in the House.
18. • Fight Colorectal Cancer will work with
stakeholder allies to achieve
reintroduction and advocate passage
of the Cancer Drug Coverage Parity
Act in the 113th Congress
19. Colorectal Cancer
Prevention, Early Detection, and
Treatment Act
• Fight Colorectal Cancer has been the impetus
behind introduction of the Colorectal Cancer
Prevention, Early Detection and Treatment Act.
This legislation would essentially expand and
improve upon the CRCCP.
The bill is authorizing legislation, which means
that even if the legislation is enacted into
law, funding to implement the law would still
need to be appropriated. In the 112th
Congress, the bill had the support of 30
cosponsors in the House and four in the Senate.
20. • Fight Colorectal Cancer will support
the reintroduction of the bill in the
113th Congress.
21. Colorectal Cancer Awareness
Month Proclamation
• President George W. Bush was the last
president to issue a proclamation declaring
March as Colorectal Cancer Awareness
Month.
Prior to then, President Bill Clinton issued a
proclamation in 2000 following the passage
of a resolution in the Senate requesting that
he designate March 2000 as National
Colorectal Cancer Awareness Month and to
issue a proclamation.
22. • Pursue introduction of a resolution in the
House and Senate that would call upon the
president to issue a proclamation declaring
March 2013 as National Colorectal Cancer
Awareness Month.
Introduction of the resolution would be a
priority in the Senate, as the House has not
been inclined as of the 112th Congress to
consider resolutions on the House floor.
23. Resources
• Fight Colorectal Cancer Advocacy
Tools
– http://fightcolorectalcancer.org/advocate
_toolbox
– http://advocacy.fightcrc.org/site/PageSer
ver
– http://fightcolorectalcancer.org